QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in TB diagnostics
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMérieux S.A. (EPA: BIM) in the German Unified Patent Court, marking a ... Read More
Bruker to acquire in-vitro diagnostics company ELITechGroup for €870m
Bruker Corporation (Nasdaq: BRKR) has solidified its position in the global life-science and diagnostics market through a definitive share purchase agreement to acquire ELITechGroup from ... Read More
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa Biotech, a California-based point-of-care molecular diagnostic company, ... Read More